Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL):
| Protocol No. | CTO-S1925 | Scope | National |
|---|---|---|---|
| Principal Investigator | Rita Assi | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase III |
